Discontinued — last reported Q3 '22
Business Segments · Deferred revenue - current
Health & Science Technologies — Deferred revenue - current
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ3 2022
Last reportedQ3 2022Oct 26, 2022
Rolls up toDeferred Revenue
How to read this metric
An increase suggests strong short-term sales momentum and a growing backlog, while a decrease may signal slowing future revenue recognition.
Detailed definition
Represents payments received from customers for goods or services that have not yet been delivered or performed, expecte...
Peer comparison
Common in companies with service contracts or long-cycle manufacturing; peers with similar business models track this as a leading indicator of revenue.
Metric ID:
iex_segment_health_science_technologies_deferred_revenue_currentHistorical Data
1 periods
| Q3 '22 | |
|---|---|
| Value | $3.20M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is IDEX's health & science technologies — deferred revenue - current?
- IDEX (IEX) reported health & science technologies — deferred revenue - current of $3.20M in Q3 2022.
- What does health & science technologies — deferred revenue - current mean?
- Cash received from customers for work that will be completed within the next year.